Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.500 |
None |
0.891 |
46 |
1
|
1995 |
2020 |
Acth-Independent Macronodular Adrenal Hyperplasia
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
46
|
8
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Glucagonoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
23
|
1
|
0.120 |
None |
1.000 |
2 |
|
2009 |
2017 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.100 |
None |
1.000 |
12 |
1
|
1995 |
2018 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.100 |
None |
1.000 |
10 |
|
2005 |
2019 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.100 |
None |
|
0 |
|
|
|
Pancreatic Neoplasm
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
764
|
20
|
0.100 |
None |
|
0 |
|
|
|
Decreased waist to hip ratio
|
phenotype |
|
Finding
|
28
|
|
0.100 |
None |
|
0 |
|
|
|
Increased glucagon level
|
phenotype |
|
Finding
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal biliary tract morphology
|
phenotype |
|
Anatomical Abnormality
|
3
|
1
|
0.100 |
None |
|
0 |
|
|
|
Abdominal Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
302
|
18
|
0.100 |
None |
|
0 |
|
|
|
Cholelithiasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
252
|
90
|
0.100 |
None |
|
0 |
|
|
|
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.090 |
None |
1.000 |
9 |
1
|
1996 |
2018 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.080 |
None |
1.000 |
8 |
|
1998 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.050 |
None |
1.000 |
5 |
1
|
1995 |
2018 |
Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.040 |
None |
1.000 |
4 |
1
|
1996 |
1999 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2020 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2014 |
Islet Cell Tumor
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
108
|
5
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.020 |
None |
0.500 |
2 |
1
|
1995 |
1996 |
Glucagon resistance
|
disease |
|
Disease or Syndrome
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Well Differentiated Pancreatic Endocrine Tumor
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
117
|
3
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
Dyslipidemias
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
471
|
184
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
945
|
50
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |